Labiana Health (XMAD:LAB) Days Payable : 140.42 (As of Dec. 2022)

View and export this data going back to 2022. Start your Free Trial

What is Labiana Health Days Payable?

Labiana Health's average Accounts Payable for the six months ended in Dec. 2022 was €11.07 Mil. Labiana Health's Cost of Goods Sold for the six months ended in Dec. 2022 was €14.39 Mil. Hence, Labiana Health's Days Payable for the six months ended in Dec. 2022 was 140.42.

The historical rank and industry rank for Labiana Health's Days Payable or its related term are showing as below:

XMAD:LAB's Days Payable is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 89.33
* Ranked among companies with meaningful Days Payable only.

Labiana Health's Days Payable increased from Dec. 2021 (0.00) to Dec. 2022 (140.42). It may suggest that Labiana Health delayed paying its suppliers.

Labiana Health Days Payable Historical Data

The historical data trend for Labiana Health's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Labiana Health Days Payable Chart

Labiana Health Annual Data

Trend

Dec20

Dec21

Dec22

Days Payable

137.97

146.11

144.11

Labiana Health Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22
Days Payable	-	-	163.49	140.42

Competitive Comparison of Labiana Health's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, Labiana Health's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Labiana Health's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Labiana Health's Days Payable distribution charts can be found below:

* The bar in red indicates where Labiana Health's Days Payable falls into.

Labiana Health Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Labiana Health's Days Payable for the fiscal year that ended in Dec. 2022 is calculated as

	Days Payable (A: Dec. 2022 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2021 )	+	Accounts Payable (A: Dec. 2022 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2022 )	*	Days in Period
=	( (8.583	+	11.328)	/	2 )	/	25.215	*	365
=	9.9555					/	25.215	*	365
=	144.11

Labiana Health's Days Payable for the quarter that ended in Dec. 2022 is calculated as:

	Days Payable (Q: Dec. 2022 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2022 )	+	Accounts Payable (Q: Dec. 2022 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2022 )	*	Days in Period
=	( (10.814	+	11.328)	/	2 )	/	14.389	*	365 / 2
=	11.071					/	14.389	*	365 / 2
=	140.42

Labiana Health Days Payable Related Terms

Thank you for viewing the detailed overview of Labiana Health's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Labiana Health (XMAD:LAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Labiana Health SA (XMAD:LAB) » Definitions » Days Payable

Traded in Other Exchanges

N/A

Address

Avenida Europa, 34 1st D, Pozuelo de Alarcon, Madrid, ESP, 28023

Website

https://www.labiana.com

Labiana Health SA is a manufacturer of pharmacological products for veterinary use. The company's activities include GMP manufacturer for EU animal and human health industries, manufacturer specialized in sterile and lyophilized dosage forms, source of development, acquisition, and licensing of molecules such as Fosfomycin Trometamol.